Compounds and their use for reducing uric acid levels
US10752613B2 · kind B2 · utility
2Cited by
12References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2017 |
| Grant date | Aug 25, 2020 |
| Priority date | — |
| Expiry date | Jun 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing uric acid levels in blood or serum, for treating disorders of uric acid metabolism, and for maintaining normal uric acid levels in blood or serum are also provided. Pharmaceutical compositions comprising the bifunctional and monofunctional compounds are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.